High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection
- PMID: 20861743
- DOI: 10.1097/QAI.0b013e3181f25bab
High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection
Abstract
For unclear reasons, about 50% of HIV-infected subjects harbour CXCR4-using (X4) viral strains in addition of CCR5-using (R5) viral strains at late stages of the disease. One hypothesis is that a low CD4(+) T-cell surface CCR5 density could facilitate the emergence of X4 strains. Alternatively, one could argue that a high CD4(+) T-cell surface CXCR4 density that is observed in individuals presenting with X4 strains, could favour R5 to X4 switch. Here, we tested both hypotheses. In vivo, we observed by quantitative flow cytometry no difference in CD4(+) T-cell surface CCR5 densities between patients with or without X4 strains. In the course of an in vitro R5 infection, the delay of emergence of X4 mutants was similar between cells expressing 2 distinct cell surface CCR5 densities, but shorter (12 ± 0 days and 21 ± 0 days, respectively, P = 0.01) in cells expressing a high surface CXCR4 density as compared with cells with a low surface CXCR4 density. These data argue for a role of CXCR4 density, but not of CCR5 density, in the emergence of X4 strains. They are reassuring concerning the risk of inducing an R5 to X4 switch using CCR5 antagonists to treat HIV infection.
Similar articles
-
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.J Virol. 2020 Jun 1;94(12):e00193-20. doi: 10.1128/JVI.00193-20. Print 2020 Jun 1. J Virol. 2020. PMID: 32295903 Free PMC article.
-
CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):530-6. J Acquir Immune Defic Syndr. 2005. PMID: 16044003
-
Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.Microbes Infect. 2015 May;17(5):378-86. doi: 10.1016/j.micinf.2015.02.002. Epub 2015 Apr 1. Microbes Infect. 2015. PMID: 25839960
-
Relationships Between HIV-Mediated Chemokine Coreceptor Signaling, Cofilin Hyperactivation, Viral Tropism Switch and HIV-Mediated CD4 Depletion.Curr HIV Res. 2019;17(6):388-396. doi: 10.2174/1570162X17666191106112018. Curr HIV Res. 2019. PMID: 31702526 Review.
-
HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function.J Leukoc Biol. 2000 Sep;68(3):331-7. J Leukoc Biol. 2000. PMID: 10985248 Review.
Cited by
-
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load.Antimicrob Agents Chemother. 2012 Aug;56(8):4154-60. doi: 10.1128/AAC.00409-12. Epub 2012 May 21. Antimicrob Agents Chemother. 2012. PMID: 22615275 Free PMC article.
-
CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.Sci Rep. 2016 Aug 4;6:30927. doi: 10.1038/srep30927. Sci Rep. 2016. PMID: 27489023 Free PMC article.
-
Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):239-44. doi: 10.1097/QAI.0000000000000127. J Acquir Immune Defic Syndr. 2014. PMID: 24508837 Free PMC article.
-
Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors.Antimicrob Agents Chemother. 2011 Oct;55(10):4664-9. doi: 10.1128/AAC.00753-11. Epub 2011 Aug 1. Antimicrob Agents Chemother. 2011. PMID: 21807977 Free PMC article.
-
CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women.J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):221-8. doi: 10.1097/QAI.0b013e31823fd215. J Acquir Immune Defic Syndr. 2012. PMID: 22083068 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials